Publications by authors named "Stephanie Heldner"

Claim this Profile
O
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.
Jorge A Marrero, Masatoshi Kudo, Alan P Venook, Sheng-Long Ye, Jean-Pierre Bronowicki, Stephanie Heldner

J Hepatol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.
Masatoshi Kudo, Riccardo Lencioni, Jorge A Marrero, Alan P Venook, Jean-Pierre Bronowicki, Stephanie Heldner

Liver Int· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.
Jean-François Geschwind, Masatoshi Kudo, Jorge A Marrero, Alan P Venook, Xiao-Ping Chen, Stephanie Heldner

Radiology· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration.
Frank G Holz, Ramin Tadayoni, Stephen Beatty, Alan Berger, Matteo G Cereda, Stephanie Heldner

Br J Ophthalmol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of patients receiving moxifloxacin for acute bacterial rhinosinusitis in clinical practice: results from an international, observational cohort study.
Ralph Mösges, Martin Desrosiers, Pierre Arvis, Stephanie Heldner

PLoS One· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moxifloxacin in complicated skin and skin structure infections (cSSSIs): A prospective, international, non-interventional, observational study.
Johannes R Bogner, Ammar Kutaiman, Melanie Esguerra-Alcalen, Stephanie Heldner, Pierre Arvis

Adv Ther· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.
Antonio Anzueto, Marc Miravitlles, Santiago Ewig, Delfino Legnani, Stephanie Heldner

Respir Med· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis